Brain-wide mapping reveals widespread GLUT4 downregulation and region-specific perineuronal net remodeling following prolonged hypercaloric diet

Metabolic disorders trigger low-grade brain inflammation, disrupting neuronal homeostasis and plasticity. A key factor is impaired glucose handling: besides insulin-independent transport, the insulin-sensitive transporter GLUT4 ensures energy supply in specific metabolic conditions, and its dysfunction promotes brain insulin resistance and cognitive decline. Energy deficits may also affect the extracellular matrix (ECM), which sustains circuit stability. Among ECM components, perineuronal nets (PNNs), structures surrounding mainly parvalbumin-positive (PV+) interneurons, are crucial for network regulation. However, there is still little information on the distribution of GLUT4 in the whole brain and the possible link with ECM plasticity players, both in normal physiological conditions and in metabolic challenge. Here, we developed a high-throughput automated workflow to map brain-wide GLUT4, PNNs, and PV+ cells in mice maintained on a standard diet (SD) or a high-fat diet (HFD) for 12 months. To evaluate whether metabolic normalization could restore impaired marker expression, two additional HFD groups were treated with widely used antidiabetic drugs: the DPP-4 inhibitor linagliptin and the sulfonylurea glimepiride. In SD-fed mice, GLUT4 expression was mainly found in the gray matter, with highest levels in the cortex. Chronic HFD induced a type 2 diabetes-like phenotype accompanied by a nearly global reduction of GLUT4 and cortex-specific PNN alterations. Pharmacological treatments produced modest effects, failing to restore central GLUT4 or PNN expression. These findings highlight that metabolic stress disrupts both GLUT4 and PNN homeostasis and suggest that preserving brain health under metabolic challenge demands therapeutic approaches that extend beyond peripheral glucose regulation.

Authors

Institutions

Publication Details

Journal
Nutrition and Diabetes
Published
2026-11-12
DOI
https://doi.org/10.1038/s41387-026-00473-3
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Brain-wide mapping reveals widespread GLUT4 downregulation and region-specific perineuronal net remodeling following prolonged hypercaloric diet

Alessandra Oberto, Thomas Nyström, Ellen Vercalsteren, Eleonora Aimaretti et al.
Nutrition and Diabetes
Neuroscience and Neuropharmacology Research
article

Brain-wide mapping reveals widespread GLUT4 downregulation and region-specific perineuronal net remodeling following prolonged hypercaloric diet

Alessandra Oberto, Thomas Nyström, Ellen Vercalsteren, Eleonora Aimaretti, Ilaria Bertocchi, Lorenzo Cifarelli, Vladimer Darsalia, Federico Luzzati, Massimo Collino, Cesare Patrone, Thomas Klein
article en

Abstract

Metabolic disorders trigger low-grade brain inflammation, disrupting neuronal homeostasis and plasticity. A key factor is impaired glucose handling: besides insulin-independent transport, the insulin-sensitive transporter GLUT4 ensures energy supply in specific metabolic conditions, and its dysfunction promotes brain insulin resistance and cognitive decline. Energy deficits may also affect the extracellular matrix (ECM), which sustains circuit stability. Among ECM components, perineuronal nets (PNNs), structures surrounding mainly parvalbumin-positive (PV+) interneurons, are crucial for network regulation. However, there is still little information on the distribution of GLUT4 in the whole brain and the possible link with ECM plasticity players, both in normal physiological conditions and in metabolic challenge. Here, we developed a high-throughput automated workflow to map brain-wide GLUT4, PNNs, and PV+ cells in mice maintained on a standard diet (SD) or a high-fat diet (HFD) for 12 months. To evaluate whether metabolic normalization could restore impaired marker expression, two additional HFD groups were treated with widely used antidiabetic drugs: the DPP-4 inhibitor linagliptin and the sulfonylurea glimepiride. In SD-fed mice, GLUT4 expression was mainly found in the gray matter, with highest levels in the cortex. Chronic HFD induced a type 2 diabetes-like phenotype accompanied by a nearly global reduction of GLUT4 and cortex-specific PNN alterations. Pharmacological treatments produced modest effects, failing to restore central GLUT4 or PNN expression. These findings highlight that metabolic stress disrupts both GLUT4 and PNN homeostasis and suggest that preserving brain health under metabolic challenge demands therapeutic approaches that extend beyond peripheral glucose regulation.

Nutrition and Diabetes
Boehringer Ingelheim (Germany) (DE), Karolinska Institutet (SE), Stockholm South General Hospital (SE), Neuroscience Institute Cavalieri Ottolenghi (IT), University of Turin (IT)
Hjärt-Lungfonden, Università degli Studi di Torino, Medical Research Council
Good health and well-being
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon